What should you expect after cataract surgery?

How cataract surgery changes vision

A cataract is clouding of the eye’s natural crystalline lens. In the usual phacoemulsification operation, the surgeon makes a small incision, opens the front of the lens capsule, uses ultrasound to break up the cloudy lens, removes the fragments by suction and places a clear artificial lens inside the capsule. The remaining capsule supports the implant. The optical target is planned before surgery: the IOL cannot restore vision lost from separate retinal, optic-nerve or corneal disease. The NHS describes these operative steps; NHS England’s decision aid explains that a focus for near or distance vision is chosen during assessment.

After the operation, transient blur can reflect dilating drops, mild inflammation or the eye’s adjustment to its new optics. Some redness, watering, grittiness or light sensitivity may occur, but symptoms should trend towards improvement. A person can have a technically successful lens replacement and still have limited vision if another eye condition affects sight; individual expectations are therefore part of the preoperative discussion, not a guarantee based on the lens label alone. Guy’s and St Thomas’ NHS Foundation Trust notes that recovery may take several weeks and that diabetes, glaucoma or macular degeneration can limit the visual result.

What the recovery and review evidence tells us

The practical question is not whether follow-up matters, but which people need an early in-person check and how everyone can obtain timely assessment if symptoms or examination findings raise concern. NICE recommends giving people postoperative information about expected visual changes, warning symptoms, activity restrictions, drops, pain relief, whom to contact and the next appointment. For uncomplicated surgery it advises against a routine in-person first-day review; this is a service recommendation, not a direction to miss a clinician-arranged appointment or to manage a complication alone. NICE NG77, recommendations 1.1.5–1.1.6 and 1.9.1–1.9.3.

Tinley and colleagues conducted a randomised trial in Southampton, UK, examining omission of the first-day review after phacoemulsification. Of 362 patients, 188 were assigned to same-day discharge (SDD) and 174 to next-day review (NDR); both groups had a planned review at about two weeks. Among the NDR group, 14/174 (8.0%) received treatment for raised intraocular pressure of 25–48 mmHg on day one; four needed increased topical steroids for uveitis (two) or corneal oedema (two), and one had a significant wound leak. Twelve/174 (6.9%) had an extra review before the two-week appointment, for drop toxicity (six), raised pressure (five) or corneal abrasion (one). In SDD, 6/188 (3.2%) returned before the planned appointment for symptom reassurance (three), drop toxicity (one) or follow-up of previously raised pressure (one); two iris prolapses were recorded, one with an early review already arranged.

At the approximately two-week review, 83% in each group achieved visual acuity of 6/12 or better (p=0.96). On a Snellen chart, 6/12 means seeing at six metres detail that a standard observer can resolve at 12 metres; it describes measured acuity and is not, by itself, a legal driving-eligibility test. At four months, the VCM1 questionnaire index showed “no or hardly any concern about vision” in 67% of SDD and 72.5% of NDR participants (p=0.26). These results found no statistically significant difference in the reported visual outcomes, but a non-significant result is not proof that risks are identical. The study’s practical lesson is narrower: selected patients in that service could be discharged on the day when planned follow-up and a route back for concerns remained in place. It did not test absence of all follow-up, and the 2003 setting and sample cannot establish an individual’s current risk. Tinley et al., abstract and trial report.

What can feel normal, and what should improve

Vision may be blurred for hours after pupil-dilating drops and can take days or a few weeks to become clearer. A mild ache, watering, grittiness or brighter-than-usual light may occur early. It is the direction of change that matters: routine irritation should ease rather than intensify. Persistent or worsening blur deserves clinical advice even if it is not painful. The NHS describes several days before improvement for many people; the Guy’s and St Thomas’ patient guidance says blur can persist for the first week and vision may take a few weeks to improve. These ranges describe experiences, not a deadline by which every eye must recover. NHS; Guy’s and St Thomas’.

Use prescribed drops exactly as directed, including the order and duration if more than one bottle is supplied. Wash hands before handling drops, avoid touching the bottle tip to the eye, and ask the surgical team or pharmacist if a dose is missed or a bottle is difficult to use. Do not stop a steroid or antibiotic early, extend it, or restart a medicine based on general web advice. Protect the eye from rubbing or accidental knocks. Local instructions differ about shields, washing, makeup, swimming, bending and strenuous activity; the operating team’s written instructions take precedence over generic timetables. Do not drive until vision meets the applicable legal standard and the clinician has advised it is safe. NICE; NHS recovery guidance.

Follow-up, glasses and travel are separate decisions

A planned review checks recovery and addresses drops, changing vision, glasses timing, the unoperated eye and any other eye conditions. The interval varies with local arrangements and individual risk: NICE says not to offer routine first-day review after uncomplicated surgery, while the NHS patient page describes a follow-up appointment and the Guy’s and St Thomas’ service commonly arranges a check within six weeks. These are examples of distinct care pathways, not contradictory guarantees. Ask before discharge who will review you, when, and how to reach an eye clinician outside clinic hours. NICE; Guy’s and St Thomas’.

A new glasses prescription is usually considered after the eye has had time to settle and the clinician or optometrist has assessed the result. If the second eye is also due for surgery, it can be sensible to wait until both eyes have been treated before finalising glasses. Travel is a different question from visual recovery: the evidence above did not study flying or travel after surgery. Before leaving the area, ask the surgeon whether your individual operation or eye health calls for an early check, what symptoms require immediate care, where that care is available, and how your records and prescribed drops will be managed. Do not treat a routine review interval as a travel clearance.

Just Clinic Istanbul is an independent marketing and lead-generation platform, not a healthcare provider or medical tourism intermediary. Enquiries may be shared with authorised healthcare partners with your consent. If you are comparing information about monofocal cataract surgery cost in Turkey or a monofocal cataract surgery package, check what is included and who provides postoperative assessment and urgent care. A package description does not establish a clinical plan, guarantee a result or replace a named surgeon’s advice.

Urgent warning signs after cataract surgery

Contact the operating eye team or the urgent eye service they identified promptly for severe or increasing pain, rapidly worsening or suddenly blurred vision, increasing redness or eyelid swelling, thick or sticky discharge, or vision that improves and then becomes worse. New distortion or wavy lines, flashes, a sudden shower or marked increase in floaters, or a dark curtain or shadow across vision also needs urgent assessment. These symptoms can signal serious problems, including infection or retinal complications; online information cannot distinguish their cause. Severe pain or a rapid loss of vision is an emergency. If the surgical team cannot be reached, use the local emergency ophthalmology service or emergency department. NHS urgent advice; Guy’s and St Thomas’ postoperative warning list.

Some mild grittiness, watering or temporary blur can occur, but do not wait for a scheduled follow-up if symptoms are severe, new or worsening. If you are outside the UK, NHS 111 is not the appropriate contact: use the emergency instructions supplied by your treating service and local urgent eye-care pathway. Keep the operation details and medication list available when seeking help.

Monofocal, multifocal and trifocal lens trade-offs

Monofocal IOLs provide one principal focal distance. The surgical team and patient agree whether that target should favour distance or another range; glasses may still be needed for tasks outside the chosen focus. Multifocal optics divide light between focal ranges, while trifocal designs aim to provide distance, intermediate and near foci. The optical mechanism can increase the chance of seeing at more than one distance without spectacles, but distributing light can also reduce contrast or produce glare and halos. Trifocal is a specific multifocal design, so pooled findings for multifocal lenses as a whole should not be read as a direct estimate for every trifocal model.

Cao and colleagues searched four databases for randomised trials in people aged 50 or older with cataract, comparing multifocal with monofocal IOLs. Their synthesis included 21 trials and 2,951 participants. The abstract reports no statistically significant difference in uncorrected or corrected distance acuity. At 60 cm, pooled mean differences favoured multifocal lenses for uncorrected intermediate acuity (−0.06; 95% CI −0.10 to −0.03) and distance-corrected intermediate acuity (−0.09; 95% CI −0.12 to −0.06); near acuity differences were −0.13 (95% CI −0.20 to −0.07) uncorrected and −0.31 (95% CI −0.43 to −0.19) with distance correction. The authors extracted binocular logMAR acuity and pooled the last reported follow-up; median follow-up was 6 months (range 1–18). ETDRS, Bailey–Lovie logMAR and other charts were used across trials, so scale harmonisation and measurement variation matter. Multifocal groups had lower contrast-sensitivity scores (mean difference −0.06; 95% CI −0.11 to −0.02), greater spectacle freedom (RR 2.86; 95% CI 1.73–4.73), and higher risks of reported glare (RR 1.91; 95% CI 1.24–2.95) and halos (RR 3.08; 95% CI 2.11–4.49). These relative effects do not give an individual’s absolute probability; definitions, lens models and measurement methods varied across trials. Cao et al..

Imburgia and colleagues conducted a prospective, non-randomised case series at San Marino State Hospital. It included adults with bilateral cataract, regular corneal tomography and astigmatism no greater than 0.75 dioptres; previous eye surgery and conditions likely to affect visual acuity were exclusions. Forty-eight people (mean age 69.7 years, SD 7.8; range 52–83) received bilateral surgery, with three lens groups of 16 people (32 eyes per group), and all completed 12-month follow-up. Measurements at one, three and 12 months included uncorrected and corrected distance acuity, intermediate acuity at 70 cm, near acuity at 30 cm, refraction, defocus curves, contrast sensitivity, optical aberrations, satisfaction, visual disturbances and spectacle dependence. In logMAR notation, a lower number represents better acuity. At 12 months, monocular uncorrected intermediate acuity (logMAR mean, SD) was 0.06 (0.05) for RayOne, 0.09 (0.05) for PanOptix and 0.56 (0.05) for monofocal; uncorrected near acuity was 0.03 (0.04), 0.04 (0.05) and 0.58 (0.09), respectively. The paper reports p<0.001 for each trifocal-versus-monofocal intermediate and near comparison. Contrast sensitivity was higher in the monofocal group at tested spatial frequencies, while satisfaction was similar between the two trifocal models. The small, non-randomised case series does not establish a general ranking across lens models or suitability for an individual. Imburgia et al..

Lens choice should reflect the eye examination, corneal and retinal health, astigmatism, previous refractive surgery, work and hobbies, night driving, tolerance for optical phenomena, preferred distance focus and willingness to use glasses. Ask what lens model is proposed, what focal target is planned for each eye, what spectacle use is realistic, and what trade-offs are relevant to your own eyes. For information on a trifocal cataract surgery price in Turkey or a trifocal cataract surgery package, separate commercial scope from clinical suitability; neither price nor package label indicates superior safety or recovery.

Questions to take to the ophthalmology team

• What visual result is realistic given my retina, optic nerve, cornea and other diagnoses?
• Which IOL model and focus target are being proposed for each eye, and what will I probably need spectacles for?
• Which symptoms are expected in my case, and which contact should I use day or night if vision worsens?
• When and with whom is my review arranged, and who will take responsibility for eye drops and any existing glaucoma or other eye medicines?
• When should I arrange glasses, return to driving or work, and resume the activities restricted in my own instructions?
• If I plan to travel, is there a clinical reason to remain near the operating team, and where should I seek urgent eye care while away?
• Who is the treating provider, and how will consented enquiries be shared with authorised healthcare partners?

References

1. Tinley CG, Frost A, Hakin KN, McDermott W, Ewings P. Is visual outcome compromised when next day review is omitted after phacoemulsification surgery? A randomised control trial. British Journal of Ophthalmology. 2003 Nov;87(11):1350–1355. doi: 10.1136/bjo.87.11.1350. PMID: 14609832; PMCID: PMC1771915.
2. Cao K, Friedman DS, Jin S, Yusufu M, Zhang J, Wang J, Hou S, Zhu G, Wang B, Xiong Y, Li J, Li X, He H, Chai L, Wan XH. Multifocal versus monofocal intraocular lenses for age-related cataract patients: a system review and meta-analysis based on randomized controlled trials. Survey of Ophthalmology. 2019 Sep–Oct;64(5):647–658. Published online 6 March 2019. doi: 10.1016/j.survophthal.2019.02.012. PMID: 30849425.
3. Imburgia A, Gaudenzi F, Mularoni K, Mussoni G, Mularoni A. Comparison of clinical performance and subjective outcomes between two diffractive trifocal intraocular lenses (IOLs) and one monofocal IOL in bilateral cataract surgery. Frontiers in Bioscience (Landmark Edition). 2022 Jan 24;27(2):41. doi: 10.31083/j.fbl2702041. PMID: 35226984.
4. National Institute for Health and Care Excellence. Cataracts in adults: management. NICE guideline NG77. Published 26 October 2017; recommendations reviewed 20 May 2025. Recommendations.
5. National Health Service. Cataract surgery. Page last reviewed 6 March 2025. NHS patient guidance.
6. Guy’s and St Thomas’ NHS Foundation Trust. After cataract surgery. Resource 3096/VER6. Last reviewed April 2026. Patient guidance.
7. NHS England; Winton Centre for Risk and Evidence Communication. Making a decision about cataracts. Decision aid version 1.1. Updated July 2022. Funding: NHS England. Conflicts of interest: none declared. PDF.
8. The Royal College of Ophthalmologists; Royal National Institute of Blind People. Understanding Series – Cataracts. Patient information booklet SE180804, version 002. Produced June 2025; exact day not stated; review due June 2028. PDF.